Navigation Links
Volcano Reports Second Quarter Results; Medical Segment Revenues Increase More Than 13 Percent On A Constant Currency Basis
Date:8/5/2013

p>1.11.4(19)(0.2)(14)(5)Europe

4.22.850-347Rest of world

3.52.9230.1221Total Consoles

$   20.5$   18.99$(0.1)-9IVUS single-procedure disposables:United States

$   40.0$   40.1-

%$
--

%-

%Japan

41.350.7(18)(7.5)(14)(4)Europe

12.210.912-111Rest of world

4.43.429--29Total IVUS single-procedure disposables

$   97.8$105.1(7)$(7.5)(7)-FFR single-procedure disposables:United States

$   28.7$   24.318

%$
--

%18

%Japan

8.95.080(1.6)(33)113Europe

15.912.6260.1125Rest of world

2.01.265--65Total FFR single-procedure disposables

$   55.5$   43.129$(1.5)(3)32Other

$   16.9$   13.425

%$(0.6)(5)

%30

%Sub-total medical segment

$190.7$180.56$(9.7)(5)11Industrial segment

$
3.8$
5.2(27)--(27)Total

$194.6$185.75$(9.7)(5)10 

 VOLCANO CORPORATIONRECONCILIATION OF GAAP RESULTS TO NON-GAAP RESULTS(in thousands, except per share data)(Unaudited)Three Months Ended June 30, 2013Pre-tax AdjustmentsNet of Tax (1)Earnings Per ShareGAAP net loss $ (2,388)$ (0.04)Acquisition related items

9115650.01Amortization of intangibles

8205080.01Non-cash interest expense on convertible notes

4,6962,9120.05Non-GAAP net income

$ 6,427$ 1,597$ 0.03Weighted average shares outstanding—diluted 54,574Six Months Ended June 30, 2013Pre-tax AdjustmentsNet of Tax (1)Earnings Per ShareGAAP net loss $ (5,549)$ (0.10)Acquisition related items

2,4891,5430.03Amortization of intangibles

1,6541,0250.02Non-cash interest expense on convertible notes

9,2685,7460.11Non-GAAP net income income

$ 13,411$ 2,765$ 0.06Weighted average shares outstanding—diluted 54,389(1) Effective tax rate of 38% applied to non-GAAP adjustments 
'/>"/>

SOURCE Volcano Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Volcano Corporation Presentation At JMP Securities Conference To Be Webcast
2. Volcano to Highlight its Leadership in Precision Guided Therapy at EuroPCR 2012
3. Volcano Corporation Presentation At Jefferies Conference To Be Webcast
4. Volcano Corporation Presentation at Wells Fargo Conference to be Webcast
5. Volcano Corporation Schedules Second Quarter Conference Call, Webcast
6. Volcano Corporation Reports 13 Percent Growth In Second Quarter Revenues; FFR Disposable Revenues Increase 38 Percent
7. Volcano Corporation Presentation At Canaccord Genuity Conference To Be Webcast
8. FAME 2 Published in the New England Journal of Medicine, Volcano participates in the $84M NIH-Sponsored ISCHEMIA Trial
9. Volcano Corporation Presentation At Stifel Nicolaus Conference To Be Webcast
10. Volcano Announces Previous St. Jude Medical Products Infringe Volcano Patent and Jury Verdicts in Patent Trials with St. Jude Medical
11. Volcano Corporation Schedules Third Quarter Conference Call, Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... DALLAS , July 1, 2015 ... Reagents and Equipment Market by Method (Biochemical (Calcium Phosphate, ... Protein Production) - Analysis & Global Forecast to 2020", ... is expected to reach around $957.9 Million by 2020 ... Browse 116 market T ables ...
(Date:7/1/2015)... -- Celsion Corporation (NASDAQ: CLSN ), an oncology drug ... , Chairman, President and CEO, is scheduled to present ... July 8, 2015, at 4:15 p.m. Eastern Time. The conference ... at 119 W. 56th Street, New York ... the presentation will be available in the Events & ...
(Date:7/1/2015)... Radiant Insights announce that it ... Market Shares, Strategy, and Forecasts, Worldwide, 2015 to ... as the aging population worldwide needs homecare oxygen treatment. ... oxygen is able to improve the quality of the ... affordable and support a mobile lifestyle even while on ...
Breaking Medicine Technology:Transfection Reagents and Equipment Market Worth $957.9 Million by 2020 2Transfection Reagents and Equipment Market Worth $957.9 Million by 2020 3Transfection Reagents and Equipment Market Worth $957.9 Million by 2020 4Celsion Corporation to Present at Cantor Fitzgerald's Inaugural Healthcare Conference on July 8, 2015 2Stationary Oxygen Concentrators Market to Reach $2 Billion by 2021: Radiant Insights, Inc. 2Stationary Oxygen Concentrators Market to Reach $2 Billion by 2021: Radiant Insights, Inc. 3Stationary Oxygen Concentrators Market to Reach $2 Billion by 2021: Radiant Insights, Inc. 4
... Than for Asthma,Rheumatoid Arthritis and Migraines, WAYNE, Pa., ... of,four ulcerative colitis (UC) sufferers (73 percent) responding ... has become a normal part,of life. Furthermore, they ... relationship with a spouse (64 percent), their sexual,relations ...
... - Results,published this week in The Lancet show ... (Types 6, 11,16, 18) Recombinant Vaccine) was 100 ... caused by HPV,types 16 and 18, two types ... was observed in women who were not,infected with ...
Cached Medicine Technology:Ulcerative Colitis (UC) Sufferers Find UC Quite Disruptive to Many,Aspects of Daily Life 2Ulcerative Colitis (UC) Sufferers Find UC Quite Disruptive to Many,Aspects of Daily Life 3Ulcerative Colitis (UC) Sufferers Find UC Quite Disruptive to Many,Aspects of Daily Life 4Ulcerative Colitis (UC) Sufferers Find UC Quite Disruptive to Many,Aspects of Daily Life 5Ulcerative Colitis (UC) Sufferers Find UC Quite Disruptive to Many,Aspects of Daily Life 6Ulcerative Colitis (UC) Sufferers Find UC Quite Disruptive to Many,Aspects of Daily Life 7Ulcerative Colitis (UC) Sufferers Find UC Quite Disruptive to Many,Aspects of Daily Life 8Ulcerative Colitis (UC) Sufferers Find UC Quite Disruptive to Many,Aspects of Daily Life 9Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 2Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 3Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 4Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 5Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 6Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 7Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 8Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 9Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 10Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 11Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 12Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 13Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 14Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 15Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 16Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 17Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 18Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 19Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 20Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 21Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 22Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 23Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 24Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 25Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 26Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 27Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 28
(Date:7/1/2015)... ... July 01, 2015 , ... The 28th annual Charity Horse Show hosted ... 11, 2015, at 6 p.m. in Pugh Bourne Park, 343 Oakfield Road. The event ... petting zoo, an Elvis impersonator, a silent auction and concessions. , Horses and riders ...
(Date:7/1/2015)... ... ... Convoy of Hope will partner with local businesses, churches, government ... 1, at Spring Lake Park High School. , During the celebration, Convoy of Hope ... goods and services including free food, health services, family portraits, job services, a carnival ...
(Date:7/1/2015)... ... 2015 , ... RowdMap Inc. is a proud participant on ... Identifying the High-Cost Patient Population: Insights from the Health Care Transformation Task Force.” ... . , The Healthcare Transformation Task Force is a group of private sector ...
(Date:7/1/2015)... , ... July 01, 2015 , ... Franklin University, one ... Dr. Leslie King has been named Dean of the College of ... Dr. King will promote and support the vision and mission of Franklin University via ...
(Date:7/1/2015)... ... July 01, 2015 , ... Bunion Bootie, the newest ... purchasing two or more Bunion Booties directly from their website, http://www.BunionBootie.com ... corrects misaligned toes and its ultra thin properties allow for protection against rubbing ...
Breaking Medicine News(10 mins):Health News:Convoy of Hope Hosts Community Event in the Twin Cities 2Health News:A Population Based Approach to Pay for Value: RowdMap, Inc. Contributes to Health Care Transformation Task Force White Paper 2Health News:A Population Based Approach to Pay for Value: RowdMap, Inc. Contributes to Health Care Transformation Task Force White Paper 3Health News:Franklin University Appoints Dean of College of Health & Public Administration 2Health News:Bunion Bootie, the #1 Non-Surgical Treatment for Bunion Pain, Announces Their Big Summer Sale 2
... , , , ... Medical Services,Holdings Limited (NYSE: CCM ) ("CMS" or ... imaging centers in China in terms of,revenues and the total ... initial public offering of 12,000,000 American Depositary Shares,("ADSs"), each representing ...
... , RICHMOND, Va., Dec. ... 2009 Industry Report: Virginia Hospitals and Nursing Facilities ... facilities and other health care providers. The report contains ... on providers, costs, profits and charity care. , The ...
... Dec. 11 UPMC Health Plan announced today that it has ... Science®, at no cost, to all UPMC for Life ... of the UPMC Health Plan wellness services, which focus on both ... the Insight(TM) Brain Fitness Program , is a suite of ...
... , SPRINGFIELD, Mass., Dec. 11 ... Council of America (WELCOA) Gold Well Workplace Award for its commitment ... Well Workplace Award, created by the Wellness Councils of America, is ... their worksite health promotion. MassMutual is one of only 60 ...
... on cardiovascular risk factors and treatment effects are ... patients are most likely to benefit from close ... findings published in the December 15/22, 2009, Prevention ... of the American College of Cardiology aim ...
... This release is available in German . ... of an apartment block and is located on the site of ... of the earth are kept out here as effective as nowhere ... of, e.g., the human heart. This was the motivation for ...
Cached Medicine News:Health News:Concord Medical Services Holdings Limited Announces Pricing of Initial Public Offering on the New York Stock Exchange 2Health News:Concord Medical Services Holdings Limited Announces Pricing of Initial Public Offering on the New York Stock Exchange 3Health News:VHI Releases Annual Industry Report - Highlights Hospital, Nursing Facility Efficiency 2Health News:UPMC Health Plan Offers Brain Fitness Software to Improve Health 2Health News:UPMC Health Plan Offers Brain Fitness Software to Improve Health 3Health News:MassMutual Recognized as One of America's Healthiest Companies 2Health News:MassMutual Recognized as One of America's Healthiest Companies 3Health News:New research identifies modifiable risk factors for heart disease 2Health News:New research identifies modifiable risk factors for heart disease 3Health News:New research identifies modifiable risk factors for heart disease 4Health News:New research identifies modifiable risk factors for heart disease 5Health News:New research identifies modifiable risk factors for heart disease 6Health News:Magnetic field measurements of the human heart at room temperature 2Health News:Magnetic field measurements of the human heart at room temperature 3
... Simplex™ P with Tobramycin ... Bone Cement formula, with the ... By maintaining the original formula, ... performance characteristics of Simplex™ P ...
... Flow Analyzer is a fast, clinically proven ... of low and normal-tension glaucoma., ,The Ocular ... clinically proven measurement that improves detection of ... management of glaucoma, and detection of other ...
... Flexible Dosposable Easy Insertion/Removal ... (CSS) provides absolutely reliable support to ... thereby permitting routine phacoemulsification regardless of ... easy (similar to disposable iris retractors), ...
The collagen intracanicular plugs have a smooth proprietary finish that simplifies insertion of the plug. Collagen plugs are ideal for short term, diagnostic and post-surgical occlusion. Plugs are 2m...
Medicine Products: